We Maximize the Impact of Your Data

We empower people to solve hard problems, to understand their past and act on their future. We believe data is the key to a better tomorrow and that, alongside our customers, we will build what comes next.

Our story

Founded over a decade ago in the modest confines of a Tiburon garage, Aizon began as an ambitious project and has grown into a leader in pharmaceutical manufacturing. The early photograph of our humble beginnings serves as a poignant reminder of our roots and the path of persistent innovation and dedication we have traversed.
‍
Our founders, Pep, Toni, and Pere, each bring more than 30 years of experience in creating specialized software for the pharmaceutical manufacturing sector. This deep expertise has underpinned our growth and enabled us to forge trusted relationships with our clients. For ten years, Aizon has been at the forefront of integrating advanced technology into one of the most regulated industries, pioneering the use of artificial intelligence and cloud solutions. This sets us apart: we are not just tech people in pharma, but long-standing pharma professionals with a solid background in technology.
‍

Our commitment extends beyond product development to educating the industry about the benefits of technologies such as the Internet of Things, Cloud Computing, and Artificial Intelligence. This mission has led us to global recognition and a series of notable achievements:

We pioneered the first GxP white paper and integration with AWS (Amazon Web Services)
We led the way highlighting AI applications in pharma manufacturing for the United Nations and creating the first training in AI for them
Our publication of the pioneering scientific paper on AI Algorithm Qualification in 2020 in the PDA Journal of Pharmaceutical Science and Technology was recognized with several awards, including the Frost & Sullivan award in 2020 and the APEX Award of Excellence in 2022.
CPV of the future with a self-controlled, adaptive bioreactor and its digital twin, receiving many praises from the industry.
We are members of the Regulatory Affairs and Quality Advisory Board at the PDA
And most importantly, we have earned the trust of many customers, with whom we’ve turned our scientific leadership into applied and pragmatic use of Artificial Intelligence in Pharmaceutical Manufacturing. See how it worked for them here.

Looking ahead to the launch of Aizon Execute, our AI-assisted Electronic Batch Records (eBR) solution in Q3 2024, we are poised to revolutionize the pharmaceutical manufacturing landscape. This innovation aims to speed up the industry digitization, optimize processes, reduce costs, and improve predictive accuracy, all while adhering to the highest standards of quality and compliance.
‍
Our journey from a garage to global influence and from 3 to over 100 employees reflects our unyielding commitment to improving how pharmaceuticals are manufactured and ensuring that quality and innovation continue to drive our industry forward.